Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers
Open
Phase 2/3
This trial is comparing with 2 newer combinations of treatment for acute myeloid leukaemia (AML).
It is for people who have a gene change () called FLT3 in their cancer cells.
Cancer Research UK supports this trial.
Recruitment start: 19 February 2025
Recruitment end: 31 October 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Steven Knapper Dr Richard Dillon
Cancer Research UK
Cardiff University
UK Acute Myeloid Leukaemia Working group
This is Cancer Research UK trial number CRUK/23/006.
Last reviewed: 15 May 2025
CRUK internal database number: 19961
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
